Aldeyra Therapeutics
ALDX
ALDX
89 hedge funds and large institutions have $249M invested in Aldeyra Therapeutics in 2018 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 31 increasing their positions, 13 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
35% more funds holding
Funds holding: 66 → 89 (+23)
25.21% more ownership
Funds ownership: 60.33% → 85.54% (+25%)
Holders
89
Holding in Top 10
4
Calls
$1.98M
Puts
$571K
Top Buyers
| 1 | +$14.1M | |
| 2 | +$13.2M | |
| 3 | +$4.83M | |
| 4 |
KCM
Knoll Capital Management
Miami,
Florida
|
+$4.7M |
| 5 |
EI
EAM Investors
Solana Beach,
California
|
+$4.31M |
Top Sellers
| 1 | -$4.95M | |
| 2 | -$786K | |
| 3 | -$769K | |
| 4 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
-$312K |
| 5 |
PCM
Prelude Capital Management
New York
|
-$239K |